Hypertrophic Cardiomyopathy (HCM)

November 20, 2021

The decision on the fate of the novel therapy for hypertrophic cardiomyopathy was delayed because the agency said it needed more time to consider the risk evaluation and mitigation strategy (REMS) for the drug.

November 12, 2021

November 11, 2021

In an interview with Managed Healthcare Executive®, Ty Gluckman, M.D., FACC, FAHA, provides helpful explanations of hypertrophic cardiomyopathy diagnosis and treatment

November 10, 2021

In an interview with Managed Healthcare Executive®, Ty Gluckman, M.D., FACC, FAHA, explains the definition, incidence and pathophysiology of hypertrophic cardiomyopathy.

November 09, 2021

Interviews with 32 patients shows a wide range of experiences but authors say one takeaway is a need for better coordination between HCM specialist and community cardiologists.

October 06, 2021

1 in 10 patients with early-onset atrial fibrillation have gene variants associated with a cardiac disease, most commonly some form of cardiomyopathy, according to research conducted by Vanderbilt researchers. Results would justify routinizing genetic testing of young afib patients, the researchers said.

October 06, 2021

A rare mutation of the ALPK3 gene has been shown to result in more serious cases of hypertrophic cardiomyopathy.

September 24, 2021

A company developing a new therapy for hypertrophic cardiomyopathy released data recently showing that people with the obstructive form of the disease often develop hypertension, atrial fibrillation and other forms of cardiovascular disease.

September 23, 2021

Black HCM patients were more likely than White HCM patients to have mid-ventricular obstruction, according to recently reported findings.

September 09, 2021

Japanese researchers say their study suggests that atrial fibrillation may trigger adverse events in HCM patients.